These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5067882)

  • 41. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent progress on systemic contraceptives.
    Matsumoto S
    Acta Obstet Gynaecol Jpn; 1970 Jul; 17(3):211-9. PubMed ID: 4917512
    [No Abstract]   [Full Text] [Related]  

  • 43. [Estrogen and protestational hormone treatment and neuropsychiatric problems].
    Pescetto G
    Sist Nerv; 1969; 21(6):348-62. PubMed ID: 5402451
    [No Abstract]   [Full Text] [Related]  

  • 44. Principles of oral contraception. 1. Mode of action of oral contraceptives.
    Carey HM
    Med J Aust; 1971 Dec; 2(23):1184-6. PubMed ID: 5134707
    [No Abstract]   [Full Text] [Related]  

  • 45. [Various experience with new highly effective gestagens].
    Stĕrba R
    Zentralbl Gynakol; 1968 May; 90(20):682-7. PubMed ID: 5688668
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hormonal contraception in France].
    Belaisch J
    Gynecol Obstet Fertil; 2004; 32(7-8):582-3. PubMed ID: 15450255
    [No Abstract]   [Full Text] [Related]  

  • 47. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
    [No Abstract]   [Full Text] [Related]  

  • 48. Hormone replacement therapy around and after the menopause: when and how?
    Drug Ther Bull; 1987 May; 25(9):33-6. PubMed ID: 3582181
    [No Abstract]   [Full Text] [Related]  

  • 49. [Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?].
    Ringa V; Fournier A
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):297-301. PubMed ID: 18947946
    [No Abstract]   [Full Text] [Related]  

  • 50. Estrogen-progestin increases breast cancer risk.
    Stephens MB
    J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
    [No Abstract]   [Full Text] [Related]  

  • 51. [Ovulation inhibitors also for patients with liver diseases?].
    Runnebaum B
    Munch Med Wochenschr; 1972 May; 114(21):1036-8. PubMed ID: 5068334
    [No Abstract]   [Full Text] [Related]  

  • 52. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 53. [Recommendations from a group of experts: drug therapy of the climacteric syndrome].
    Lakartidningen; 1989 Dec; 86(50):4447-9. PubMed ID: 2601514
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hormone replacement therapy for menopausal women].
    Nozaki M
    Fukuoka Igaku Zasshi; 2000 Mar; 91(3):74-9. PubMed ID: 10917758
    [No Abstract]   [Full Text] [Related]  

  • 55. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Do 3rd-generation ovulation inhibitors have a new risk profile?].
    Heinemann LA
    Dtsch Med Wochenschr; 1996 Aug; 121(34-35):1037-9. PubMed ID: 8829903
    [No Abstract]   [Full Text] [Related]  

  • 57. Postcoital contraception by topical application of some steroidal and nonsteroidal agents.
    Kar AB; Setty BS; Kamboj VP
    Am J Obstet Gynecol; 1968 Sep; 102(2):306-7. PubMed ID: 5692045
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of some progestins on pituitary gonadotrophin excretion patterns in women.
    Keller PJ
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):379-85. PubMed ID: 5510166
    [No Abstract]   [Full Text] [Related]  

  • 59. [Sequental estrogen-progestogen treatment and hepatic function in the climacteric age].
    Cazzola D
    Ann Ostet Ginecol Med Perinat; 1969 Nov; 91(11):756-73. PubMed ID: 5403945
    [No Abstract]   [Full Text] [Related]  

  • 60. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.